Risk factors for invasive fungal infection in 5‐azacytidine treated patients with acute myeloid leukemia and myelodysplastic syndrome-Reference-Cited by-同舟云学术

Risk factors for invasive fungal infection in 5‐azacytidine treated patients with acute myeloid leukemia and myelodysplastic syndrome

Published:2021-05-27 Issue:2 Volume:107 Page:181-189
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Tey Amanda¹^ORCID,Shaw Briony²,Cardamone Luke³,Shepherd Sam¹,Paul Eldho⁴,Rogers Ben³⁵,Shortt Jake²⁵^ORCID

Affiliation:

1. Pharmacy Department Monash Health Clayton Vic. Australia

2. Monash Haematology Monash Health Clayton Vic. Australia

3. Monash Infectious Diseases Monash Health Clayton Vic. Australia

4. School of Public Health and Preventive Medicine Monash Centre for Health Research and Implementation Monash University Clayton Vic. Australia

5. School of Clinical Sciences Monash University Clayton Vic. Australia

Publisher

Wiley

Subject

Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ejh.13631

Reference23 articles.

1. A population‐based analysis of invasive fungal disease in haematology‐oncology patients using data linkage of state‐wide registries and administrative databases: 2005–2016;Valentine JC;BMC Infect Dis,2019

2. Consensus guidelines for antifungal prophylaxis in haematological malignancy and haemopoietic stem cell transplantation, 2014

3. European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukaemia;Maertens JA;J Antimicrob Chemother,2018

4. Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)

5. Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Infections and antimicrobial prophylaxis in patients with myelodysplastic syndromes;Seminars in Hematology;2024-08

2. High rate of invasive fungal infections during early cycles of azacitidine for patients with acute myeloid leukemia;Frontiers in Cellular and Infection Microbiology;2022-11-30

3. Impact of treatment intensity on infectious complications in patients with acute myeloid leukemia;Journal of Cancer Research and Clinical Oncology;2022-05-18

4. Antifungal prophylaxis in adult patients with acute myeloid leukaemia treated with novel targeted therapies: a systematic review and expert consensus recommendation from the European Hematology Association;The Lancet Haematology;2022-05

5. Development and evaluation of a novel fast broad-range PCR and sequencing assay (FBR-PCR/S) using dual priming oligonucleotides targeting the ITS/LSU gene regions for rapid diagnosis of invasive fungal diseases: multi-year experience in a large Canadian healthcare zone;BMC Infectious Diseases;2022-04-13